The, Three Dimensional Printing Of Tissues

1727 WordsOct 31, 20167 Pages
Bioprinting, three-dimensional printing of tissues, will have a positive impact in the medical field through assisting patients in need of transplants and scientists in drug development without the use of humans or animals. Bioprinting will evolve as time goes on, facing legal and ethical questions in the process. Bioprinting, is the process of creating tissues through a three-dimensional printer. The original goal for bioprinting was to create working organs, but living cells that function on their own to make the organ is a more difficult feature the achieve. The research of organ printing first came up at the University of Missouri Columbia and was lead by Gabor Forgacs; he patented NovoGen™, an operating system for bioprinting. “Gabor Forgacs, who co-founded Organovo in 2007 and was the company’s scientific mastermind” (“Bioprinters,” 2014). The idea of bioprinting began at the San Diego Organovo. Sometime during the year 2007, the experimentation of creating tissues, like pieces of the lung and heart, have taken place at Organovo. Seven years from the initial official start of Organovo, their first fragment of human liver tissue goes out for commercial sale. “In January (2014) samples of its first product—slivers of human liver tissue—were delivered to an outside laboratory for testing” (“Bioprinters,” 2014). This was one of the first mass productions human tissues, created at a very quick rate, “... in sets of 24 and take about 30 minutes to produce…”
Open Document